Asia Pacific In Vitro Lung Model Market Size & Outlook
Asia Pacific in vitro lung model market, 2018-2030 (US$M)
Related Markets
Asia Pacific in vitro lung model market highlights
- The Asia Pacific in vitro lung model market generated a revenue of USD 68.8 million in 2023.
- The market is expected to grow at a CAGR of 18.8% from 2024 to 2030.
- In terms of segment, 2d model was the largest revenue generating type in 2023.
- 3D Model is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 68.8 million |
| Market revenue in 2030 | USD 229.4 million |
| Growth rate | 18.8% (CAGR from 2023 to 2030) |
| Largest segment | 2d model |
| Fastest growing segment | 3D Model |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | 2D Model, 3D Model |
| Key market players worldwide | Zoetis, Boehringer Ingelheim, Merck & Co Inc, Virbac SA, Elanco Animal Health Inc, IDEXX Laboratories Inc, HESKA, Indian Immunologicals, Kareo, NXGN |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 22.1% of the global in vitro lung model market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 229.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In Vitro Lung Model Market Scope
In Vitro Lung Model Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific in vitro lung model market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro lung model market will help companies and investors design strategic landscapes.
2d model was the largest segment with a revenue share of 56.83% in 2023. Horizon Databook has segmented the Asia Pacific in vitro lung model market based on 2d model, 3d model covering the revenue growth of each sub-segment from 2018 to 2030.
- Asia Pacific In Vitro Lung Model Type Outlook (Revenue, USD Million, 2018-2030)
- 2D Model
- 3D Model
- Asia Pacific In Vitro Lung Model Application Outlook (Revenue, USD Million, 2018-2030)
- Drug Discovery and Toxicology Studies
- Physiological Research
- 3D Model Development
- Others
- Asia Pacific In Vitro Lung Model End Use Outlook (Revenue, USD Million, 2018-2030)
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Others
Reasons to subscribe to Asia Pacific in vitro lung model market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific in vitro lung model market databook
-
Our clientele includes a mix of in vitro lung model market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific in vitro lung model market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific in vitro lung model market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific in vitro lung model market report size, by country, 2018-2030 (US$M)
Asia Pacific In Vitro Lung Model Market Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
